1 completed. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Completed 1 |
Follow PF-00299804: new trials by email Literature Review of PF-00299804 trials Research Report on PF-00299804
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| PF-00299804 in Stage IIIB or Stage IV Non-Small Cell Lung Cancer Not Responding to Standard Therapy for Advanced or Metastatic Cancer PF-00299804, Placebo - Lung Cancer | Phase 3 | Completed | NCIC Clinical Trials Group | 720 | 2009-12-23 | 2023-08-22 |
Carcinoma, Non-Small-Cell Lung (1) · Lung Neoplasms (1)
NCIC Clinical Trials Group (1)
Argentina (1) · Australia (1) · Brazil (1) · Canada (1) · Italy (1) · New Zealand (1) · Peru (1) · Philippines (1) · South Korea (1) · Taiwan (1) · Thailand (1) · United States (1)
Michael Millward, MD (1) · Penny Bradbury, MD (1) · Peter Ellis, MD (1)